Shionogi & Co (4507 JP): Change Of Gears Likely From FY26, Torii Acquisition Augurs Well
​Shionogi sees revenue rise in FY25 as royalties offset lower infectious disease drug sales. Acquisition and new drug submissions signal product...
371 Views
Japan Consumer Sector Update: Q4 FY2025 Wrap-Up and FY2026 Outlook
​Food and beverage sector raising prices and driving efficiencies for potential earnings outperformance, while alcoholic beverage makers face...
259 Views
Weekly Deals Digest (11 May) - CATL, Hengrui, Imagica, MitShokuhin, NTT Data, Shibaura, Torii, ZEEKR
A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...
482 Views
APAC Healthcare Weekly (May 11)- Shionogi, Daiichi Sankyo, HK Inno, Neuren, Biocon, Aster DM, Lupin
Shionogi is acquiring Torii Pharma. Daiichi Sankyo’s Enhertu meets key goal in breast cancer trial. HK inno got domestic approval for P3 trial of...
611 Views
Shionogi & Co (4507 JP): Torii Acquisition to Broaden Portfolio; High R&D to Dent Profitability
​Shionogi is acquiring Torii Pharmaceutical and Japan Tobacco's pharmaceutical business. With minimum portfolio overlap and promising pipeline, the...
502 Views